Search results
Results from the WOW.Com Content Network
Vascular dementia is the second-most-common form of dementia after Alzheimer's disease in older adults. [4] The prevalence of the illness is 1.5% in Western countries and approximately 2.2% in Japan. It accounts for 50% of all dementias in Japan, 20% to 40% in Europe and 15% in Latin America. 25% of people with stroke develop new-onset dementia ...
A 5-pin bowling pinsetter in use at a bowling alley in Toronto Pinsetters in operation at a bowling alley as seen from behind the lanes. In bowling, a pinsetter or pinspotter is an automated mechanical device that sets bowling pins back in their original positions, returns bowling balls to the front of the alley, and clears fallen pins on the pin deck.
Every year, thousands in the United States have a stroke, with one occurring every 40 seconds, according to the U.S. Centers for Disease Control and Prevention. The majority of strokes are ...
Assistive listening devices include FM, infrared, and loop assistive listening devices. This type of technology allows people with hearing difficulties to focus on a speaker or subject by getting rid of extra background noises and distractions, making places like auditoriums, classrooms, and meetings much easier to participate in.
Penumbra was founded in 2004 and manufactures several medical devices but specializes in the neuro/vascular market and creates devices that help treat aneurysms and ischemic stroke. [ 7 ] [ 8 ] In 2014, Penumbra launched its Apollo system, a device that “enables minimally invasive removal of deeply seated tissue and fluids in the brain ...
The applications of FES for children with cerebral palsy are similar to those for adults. Some common applications of FES devices include stimulation of muscles whilst mobilizing to strengthen muscle activity, to reduce muscle spasticity, to facilitate initiation of muscle activity, or to provide a memory of movement.
Binswanger's disease is a type of subcortical vascular dementia caused by white matter atrophy to the brain. However, white matter atrophy alone is not sufficient for this disease; evidence of subcortical dementia is also necessary.
Balt was established in 1977 in France as a small family business by Leopold Płowiecki. [1] His son, Nicolas, oversaw the company's growth until 2018. [2] In 2015, Bridgepoint Advisers acquired a stake in the company, and Balt began to expand internationally. [3]